Clinical Trial Facts & Figures
View charts on Public Attitudes and Perceptions
Source: Pharmaprojects
Source: CenterWatch 2010
top
Source: EvaluatePharma 2010
Source: R&D Directions, 2009
top
Source: Tufts Center for the Study of Drug Development
Source: Tufts Center for the Study of Drug Development
Source: Tufts Center for the Study of Drug Development
top
Source: Tufts Center for the Study of Drug Development
Source: CISCRP
top
Source: Getz, The Gift of Participation, 2010
Source: Food and Drug Administration
top
Source: FDA’s Bioresearch Monitoring Information System File (BMIS)
Source: Tufts Center for the Study of Drug Development
top
Source: Tufts Center for the Study of Drug Development
Source: Tufts Center for the Study of Drug Development
top
| Industry-Funded Clinical Development Activity Targeting Diseases that affect Diverse Populations |
| |
–800 medicines for diseases that disproportionately affect American women in 2010; up from 348 in 2000 |
| |
–581 medicines for diseases that disproportionately affect Hispanic Americans in 2009; up from 245 in 2001 |
| |
–709 new medicines for diseases that disproportionately afflict African Americans in 2009; up from 156 identified medicines in in 1999
|
| |
Sources: FDA; PhRMA
|
Sources: US Census Bureau; NIH; Tufts CSDD 2010
top
Sources: US Census Bureau; NIH; Tufts CSDD 2010
N=$
Source: Parexel's Bio/Pharmaceutical R&D Statistical Sourcebook 2009/2010
top
N=$
Source: Parexel's Bio/Pharmaceutical R&D Statistical Sourcebook 2009/2010
N=$
Source: Parexel's Bio/Pharmaceutical R&D Statistical Sourcebook 2009/2010
top
